Wolverine Asset Management »

Humacyte Inc-cw27 shares owned by Wolverine Asset Management

Quarter-by-quarter ownership of Humacyte Inc-cw27 (HUMAW) shares owned by Wolverine Asset Management from 13F filings

Historical chart of Wolverine Asset Management investment in Humacyte Inc-cw27

Tip: Access up to 7 years of quarterly data

All positions including Humacyte Inc-cw27 held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte Inc-cw27 by Wolverine Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.4k 8.3k 0.42
2023-09-30 $559 781 0.72
2021-09-30 $8.0k 3.0k 2.70

More positions owned by Wolverine Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ati Note 3.500% 6/1 (Principal)
Zillow Group Note 1.375% 9/0 (Principal)
Cytokinetics Note 3.500% 7/0 (Principal)
Coinbase Global Com Cl A Put Option (COIN)
Amazon Call Option (AMZN)
Royal Caribbean Cruises Put Option (RCL)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
NVIDIA Corporation Call Option (NVDA)
Li Auto Note 0.250% 5/0 (Principal)
Draftkings Note 3/1 (Principal)
Tesla Motors Call Option (TSLA)
Broadcom Call Option (AVGO)

View all positions for Wolverine Asset Management

Top funds holding Humacyte Inc-cw27

Josh Arnold Investment Consultant
Tudor Investment Corporation
Walleye Trading Advisors
Millennium Management
Jane Street
LMR Partners
Wolverine Asset Management
UBS Group

View all funds holding Humacyte Inc-cw27